Phathom Pharmaceuticals, Inc.
PHAT
$9.58
$0.404.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 42.11% | -43.60% | 29.44% | 60.46% | 19.62% |
| Total Depreciation and Amortization | 3.64% | -14.06% | -17.95% | -9.30% | -2.82% |
| Total Amortization of Deferred Charges | 8.06% | 4.33% | 4.39% | 5.59% | 5.46% |
| Total Other Non-Cash Items | -1.88% | 9.49% | -32.27% | -9.06% | 4.01% |
| Change in Net Operating Assets | 70.42% | -61.81% | 359.86% | 73.84% | 33.24% |
| Cash from Operations | 87.67% | -212.88% | 64.57% | 77.50% | 26.14% |
| Capital Expenditure | 27.87% | 29.89% | -222.22% | 72.16% | -438.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 27.87% | 29.89% | -222.22% | 72.16% | -438.89% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -97.10% | 9,588.93% | 331.74% | 266.25% | -- |
| Repurchase of Common Stock | 100.00% | 90.60% | -141.49% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.67% | 68,801.03% | 64.21% | -438.75% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.90% | 1,082.30% | 64.03% | 77.03% | 26.14% |